Imfinzi comes as a liquid solution that’s given as an intravenous (IV) infusion. This is an injection into a vein over a period of time. You’ll receive Imfinzi infusions at a clinic or in the ...

One option is an immunotherapy medicine called Imfinzi (durvalumab). Immunotherapy medicines work by helping your immune system find and attack cancer cells. The FDA approved Imfinzi in 2017.

Three more fake batches of the cancer immunotherapy have been encountered in Iran and Türkiye, warns the agency.

AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladder ...

WILMINGTON, Del., September 15, 2024--(BUSINESS WIRE)--Positive results from the NIAGARA Phase III trial showed AstraZeneca’s IMFINZI ® (durvalumab) in combination with chemotherapy ...

WILMINGTON, DE — AstraZeneca has announced positive high-level results from its Phase III POTOMAC trial assessing the efficacy of IMFINZI® (durvalumab) combined with standard-of-care Bacillus ...

Based on AEGEAN Phase III trial results which showed IMFINZI-based regimen reduced the risk of recurrence, progression or death by 32% vs. neoadjuvant chemotherapy alone WILMINGTON, Del.--( ...

WILMINGTON, Del., December 05, 2024--(BUSINESS WIRE)--AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung ...

AstraZeneca (NASDAQ:AZN) said the FDA has approved its drug Imfinzi, also known as durvalumab, for the treatment of a certain type of endometrial cancer. The FDA approved Imfinzi in combination ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved by the Food and Drug Administration for the treatment of adult patients with resectable early-stage (IIA ...

The regimen using Imfinzi, the company’s anti-PD-L1 checkpoint inhibitor, cut the risk of death by 25% compared to treating patients before surgery with chemotherapy alone, researchers reported ...

Imfinzi (durvalumab) is a brand-name infusion prescribed for certain types of cancers, including certain lung cancers. As with other drugs, Imfinzi can cause side effects, such as fatigue, rash ...